Asklepion Pharmaceuticals, LLC is a Baltimore-based company specializing in the development and research of pharmaceutical products. With a focus on acute lung injury induced by CBP (Cardiopulmonary Bypass), Asklepion is dedicated to advancing medical treatments and improving patient outcomes. Their team of experts works diligently to conduct clinical trials and develop innovative solutions to address critical medical conditions.
Generated from the website